Goodwill and Other Intangible Assets (Tables)

3 Months Ended

Mar. 31, 2021

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of Identifiable Intangible Assets Carrying Value

The net carrying value of the identifiable intangible assets from all acquisitions as of March 31, 2021 and December 31, 2020 are as follows:

		As of March 31, 2021			As of December 31, 2020
	Life	Carrying			Carrying
	(Years)	Amount			Amount
		(unaudited)
Asuragen acquisition:
Thyroid	9	$	8,519		$	8,519
RedPath acquisition:
Pancreas test	7		16,141			16,141
Barrett’s test	9		6,682			6,682
BioPharma acquisition:
Trademarks	10		1,600			1,600
Customer relationships	8		5,700			5,700
CLIA Lab	2.3	$	609		$	609
Total		$	39,251		$	39,251
Accumulated Amortization		$	(29,013	)	$	(27,900	)
Net Carrying Value		$	10,238		$	11,351

Schedule of Future Estimated Amortization Expense

Estimated amortization expense for the next five years is as follows:

2021		2022		2023		2024		2025
$	4,078	$	2,155	$	2,099	$	873	$	873

Schedule of Goodwill Carrying Value

The following table displays a roll forward of the carrying amount of goodwill from December 31, 2020 to March 31, 2021:

	Carrying
	Amount
Balance as of December 31, 2020	$	8,433
Adjustments		-
Balance as of March 31, 2021	$	8,433